nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2A—cerebellar cortex—hypothyroidism	0.109	0.136	CbGeAlD
Mesoridazine—DRD2—nerve—hypothyroidism	0.0609	0.0757	CbGeAlD
Mesoridazine—HTR2A—urine—hypothyroidism	0.0582	0.0724	CbGeAlD
Mesoridazine—CYP2D6—urine—hypothyroidism	0.053	0.0659	CbGeAlD
Mesoridazine—HTR2A—nerve—hypothyroidism	0.0401	0.0499	CbGeAlD
Mesoridazine—CHRM2—heart—hypothyroidism	0.0308	0.0383	CbGeAlD
Mesoridazine—CHRM2—cardiovascular system—hypothyroidism	0.0291	0.0362	CbGeAlD
Mesoridazine—HTR1A—cardiovascular system—hypothyroidism	0.0236	0.0294	CbGeAlD
Mesoridazine—KCNH2—heart—hypothyroidism	0.0223	0.0277	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—hypothyroidism	0.021	0.0261	CbGeAlD
Mesoridazine—DRD2—pituitary gland—hypothyroidism	0.0189	0.0235	CbGeAlD
Mesoridazine—HTR1A—adrenal gland—hypothyroidism	0.0187	0.0232	CbGeAlD
Mesoridazine—KCNH2—pituitary gland—hypothyroidism	0.0186	0.0231	CbGeAlD
Mesoridazine—KCNH2—adrenal gland—hypothyroidism	0.0166	0.0207	CbGeAlD
Mesoridazine—KCNH2—blood—hypothyroidism	0.0166	0.0207	CbGeAlD
Mesoridazine—KCNH2—female gonad—hypothyroidism	0.0155	0.0193	CbGeAlD
Mesoridazine—HTR2A—heart—hypothyroidism	0.0149	0.0185	CbGeAlD
Mesoridazine—HTR1A—cerebellum—hypothyroidism	0.0143	0.0177	CbGeAlD
Mesoridazine—HTR2A—cardiovascular system—hypothyroidism	0.0141	0.0175	CbGeAlD
Mesoridazine—DRD2—testis—hypothyroidism	0.0139	0.0173	CbGeAlD
Mesoridazine—KCNH2—testis—hypothyroidism	0.0137	0.0171	CbGeAlD
Mesoridazine—HRH1—adrenal gland—hypothyroidism	0.0133	0.0166	CbGeAlD
Mesoridazine—DRD2—cerebellum—hypothyroidism	0.0129	0.016	CbGeAlD
Mesoridazine—HTR2A—gonad—hypothyroidism	0.0128	0.0159	CbGeAlD
Mesoridazine—KCNH2—cerebellum—hypothyroidism	0.0127	0.0158	CbGeAlD
Mesoridazine—HTR2A—pituitary gland—hypothyroidism	0.0125	0.0155	CbGeAlD
Mesoridazine—HRH1—female gonad—hypothyroidism	0.0124	0.0154	CbGeAlD
Mesoridazine—HTR2A—adrenal gland—hypothyroidism	0.0111	0.0138	CbGeAlD
Mesoridazine—HTR2A—blood—hypothyroidism	0.0111	0.0138	CbGeAlD
Mesoridazine—HRH1—testis—hypothyroidism	0.011	0.0137	CbGeAlD
Mesoridazine—CYP2D6—blood—hypothyroidism	0.0101	0.0126	CbGeAlD
Mesoridazine—CYP2D6—female gonad—hypothyroidism	0.00945	0.0118	CbGeAlD
Mesoridazine—HTR2A—testis—hypothyroidism	0.0092	0.0114	CbGeAlD
Mesoridazine—HTR2A—liver—hypothyroidism	0.0087	0.0108	CbGeAlD
Mesoridazine—HTR2A—cerebellum—hypothyroidism	0.0085	0.0106	CbGeAlD
Mesoridazine—CYP2D6—testis—hypothyroidism	0.00838	0.0104	CbGeAlD
Mesoridazine—CYP2D6—liver—hypothyroidism	0.00792	0.00986	CbGeAlD
Mesoridazine—CYP2D6—cerebellum—hypothyroidism	0.00774	0.00963	CbGeAlD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000875	0.00446	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000875	0.00446	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—TRH—hypothyroidism	0.000867	0.00442	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—TRH—hypothyroidism	0.000863	0.0044	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000861	0.00439	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000861	0.00439	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000808	0.00412	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000804	0.0041	CbGpPWpGaD
Mesoridazine—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	0.00078	0.00398	CbGpPWpGaD
Mesoridazine—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	0.000779	0.00397	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—TSHR—hypothyroidism	0.000773	0.00394	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—TSHB—hypothyroidism	0.000773	0.00394	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	0.000769	0.00392	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	0.000769	0.00392	CbGpPWpGaD
Mesoridazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000763	0.00389	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—TRH—hypothyroidism	0.000761	0.00388	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—TRH—hypothyroidism	0.000749	0.00382	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—AVP—hypothyroidism	0.000749	0.00382	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—TRH—hypothyroidism	0.000748	0.00381	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000736	0.00375	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000698	0.00356	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000696	0.00355	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000686	0.0035	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—TSHB—hypothyroidism	0.000679	0.00346	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—TSHR—hypothyroidism	0.000679	0.00346	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	0.000668	0.00341	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	0.000668	0.00341	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—TSHB—hypothyroidism	0.000666	0.0034	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—TSHR—hypothyroidism	0.000666	0.0034	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—TRH—hypothyroidism	0.000662	0.00338	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000656	0.00334	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000656	0.00334	CbGpPWpGaD
Mesoridazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000619	0.00316	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—AVP—hypothyroidism	0.000615	0.00314	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—TRH—hypothyroidism	0.000601	0.00307	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000598	0.00305	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000595	0.00304	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—TSHB—hypothyroidism	0.00059	0.00301	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—TSHR—hypothyroidism	0.00059	0.00301	CbGpPWpGaD
Mesoridazine—DRD3—G alpha (i) signalling events—POMC—hypothyroidism	0.000574	0.00293	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—TRH—hypothyroidism	0.000562	0.00287	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000537	0.00274	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—TSHB—hypothyroidism	0.000536	0.00273	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—TSHR—hypothyroidism	0.000536	0.00273	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000525	0.00268	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—AVP—hypothyroidism	0.000523	0.00267	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000517	0.00264	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000516	0.00263	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TRH—hypothyroidism	0.000511	0.0026	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000507	0.00259	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—TSHB—hypothyroidism	0.000501	0.00256	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—TSHR—hypothyroidism	0.000501	0.00256	CbGpPWpGaD
Mesoridazine—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.0005	0.00255	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	0.00049	0.0025	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000488	0.00249	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000456	0.00233	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—AVP—hypothyroidism	0.000456	0.00232	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TSHB—hypothyroidism	0.000455	0.00232	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TSHR—hypothyroidism	0.000455	0.00232	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.000453	0.00231	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TRH—hypothyroidism	0.000445	0.00227	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000443	0.00226	CbGpPWpGaD
Mesoridazine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	0.000439	0.00224	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000437	0.00223	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000437	0.00223	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000435	0.00222	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000435	0.00222	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	0.00043	0.00219	CbGpPWpGaD
Mesoridazine—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000424	0.00216	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000423	0.00216	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—TRH—hypothyroidism	0.000422	0.00215	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000416	0.00212	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CLTC—hypothyroidism	0.000411	0.0021	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—POMC—hypothyroidism	0.000409	0.00209	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—AVP—hypothyroidism	0.0004	0.00204	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000398	0.00203	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	0.000397	0.00202	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	0.000397	0.00202	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000396	0.00202	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000395	0.00201	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000395	0.00201	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000394	0.00201	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—AVP—hypothyroidism	0.000393	0.002	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TRH—hypothyroidism	0.000391	0.00199	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—IYD—hypothyroidism	0.000388	0.00198	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000386	0.00197	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000384	0.00196	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TRH—hypothyroidism	0.000384	0.00196	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	0.000384	0.00196	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	0.000384	0.00196	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000378	0.00193	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000377	0.00192	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000377	0.00192	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	0.000377	0.00192	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	0.000377	0.00192	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000371	0.00189	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000371	0.00189	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	0.000361	0.00184	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TRH—hypothyroidism	0.000355	0.00181	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000349	0.00178	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CLTC—hypothyroidism	0.000349	0.00178	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.000348	0.00178	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.000348	0.00178	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AVP—hypothyroidism	0.000348	0.00177	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—POMC—hypothyroidism	0.000347	0.00177	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000343	0.00175	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000343	0.00175	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000343	0.00175	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000343	0.00175	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TSHR—hypothyroidism	0.000342	0.00174	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TSHB—hypothyroidism	0.000342	0.00174	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000337	0.00172	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000336	0.00172	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000336	0.00172	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.00033	0.00168	CbGpPWpGaD
Mesoridazine—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000329	0.00168	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—VAV3—hypothyroidism	0.000328	0.00167	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TSHB—hypothyroidism	0.000317	0.00161	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TSHR—hypothyroidism	0.000317	0.00161	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AVP—hypothyroidism	0.000316	0.00161	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TPO—hypothyroidism	0.00031	0.00158	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—VAV3—hypothyroidism	0.000307	0.00156	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000304	0.00155	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000303	0.00154	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000303	0.00154	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TRH—hypothyroidism	0.000302	0.00154	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000301	0.00154	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AVP—hypothyroidism	0.000295	0.00151	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SH2B3—hypothyroidism	0.000282	0.00144	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—VAV3—hypothyroidism	0.000278	0.00142	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TSHB—hypothyroidism	0.000269	0.00137	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TSHR—hypothyroidism	0.000269	0.00137	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AVP—hypothyroidism	0.000268	0.00137	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000267	0.00136	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CLTC—hypothyroidism	0.000267	0.00136	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000266	0.00136	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—POMC—hypothyroidism	0.000266	0.00136	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TRH—hypothyroidism	0.000263	0.00134	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000263	0.00134	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CLTC—hypothyroidism	0.000262	0.00134	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000262	0.00133	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000262	0.00133	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—POMC—hypothyroidism	0.000261	0.00133	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000258	0.00132	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	0.000257	0.00131	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000257	0.00131	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000256	0.00131	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000243	0.00124	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000241	0.00123	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SH2B3—hypothyroidism	0.00024	0.00122	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	0.000235	0.0012	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	0.000234	0.0012	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	0.000234	0.0012	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	0.000234	0.00119	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000233	0.00119	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000233	0.00119	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000233	0.00119	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—POMC—hypothyroidism	0.000231	0.00118	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000231	0.00118	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TRH—hypothyroidism	0.000231	0.00118	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	0.00023	0.00117	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.000227	0.00116	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	0.000227	0.00116	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TRH—hypothyroidism	0.000227	0.00116	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	0.000226	0.00115	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TRH—hypothyroidism	0.000223	0.00114	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000222	0.00113	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AVP—hypothyroidism	0.000222	0.00113	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	0.000218	0.00111	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	0.000213	0.00109	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—POMC—hypothyroidism	0.00021	0.00107	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	0.00021	0.00107	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PRL—hypothyroidism	0.000209	0.00107	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	0.000209	0.00107	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	0.000209	0.00107	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	0.000208	0.00106	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	0.000206	0.00105	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TSHB—hypothyroidism	0.000206	0.00105	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TSHR—hypothyroidism	0.000206	0.00105	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AVP—hypothyroidism	0.000205	0.00105	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TSHB—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TSHR—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AVP—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TSHB—hypothyroidism	0.000199	0.00101	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TSHR—hypothyroidism	0.000199	0.00101	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AVP—hypothyroidism	0.000198	0.00101	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—POMC—hypothyroidism	0.000196	0.001	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VAV3—hypothyroidism	0.000194	0.000988	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AVP—hypothyroidism	0.000187	0.000952	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	0.000183	0.000935	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	0.00018	0.00092	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	0.00018	0.000918	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—POMC—hypothyroidism	0.000178	0.000909	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PRL—hypothyroidism	0.000178	0.000907	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	0.000177	0.000904	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	0.000171	0.000873	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	0.00017	0.000868	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VAV3—hypothyroidism	0.000164	0.000839	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AVP—hypothyroidism	0.000158	0.000808	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	0.000155	0.000792	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PRL—hypothyroidism	0.000155	0.00079	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	0.000155	0.000788	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PRL—hypothyroidism	0.000154	0.000786	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	0.00015	0.000766	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	0.000148	0.000754	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	0.000147	0.000752	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	0.000145	0.00074	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TSHB—hypothyroidism	0.000144	0.000732	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	0.000143	0.000731	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	0.000143	0.000727	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AVP—hypothyroidism	0.000138	0.000704	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AVP—hypothyroidism	0.000137	0.000701	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—POMC—hypothyroidism	0.000136	0.000696	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PRL—hypothyroidism	0.000136	0.000694	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	0.000134	0.000685	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—POMC—hypothyroidism	0.000134	0.000683	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PRL—hypothyroidism	0.000134	0.000683	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PRL—hypothyroidism	0.000134	0.000681	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—POMC—hypothyroidism	0.000132	0.000672	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PRL—hypothyroidism	0.000131	0.00067	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	0.000128	0.000652	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VAV3—hypothyroidism	0.000126	0.000642	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—POMC—hypothyroidism	0.000124	0.000632	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	0.000124	0.000632	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VAV3—hypothyroidism	0.000124	0.00063	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VAV3—hypothyroidism	0.000122	0.00062	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AVP—hypothyroidism	0.000121	0.000618	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AVP—hypothyroidism	0.000119	0.000609	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IGF1—hypothyroidism	0.000119	0.000608	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AVP—hypothyroidism	0.000119	0.000607	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AVP—hypothyroidism	0.000117	0.000597	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	0.000107	0.000548	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—POMC—hypothyroidism	0.000105	0.000537	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF1—hypothyroidism	0.000101	0.000517	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—POMC—hypothyroidism	9.18e-05	0.000468	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—POMC—hypothyroidism	9.13e-05	0.000466	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	8.83e-05	0.00045	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	8.78e-05	0.000448	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—hypothyroidism	8.06e-05	0.000411	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—hypothyroidism	7.93e-05	0.000404	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—hypothyroidism	7.91e-05	0.000404	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—hypothyroidism	7.78e-05	0.000397	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1—hypothyroidism	7.75e-05	0.000395	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	7.63e-05	0.000389	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1—hypothyroidism	7.61e-05	0.000388	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1—hypothyroidism	7.49e-05	0.000382	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—hypothyroidism	5.62e-05	0.000287	CbGpPWpGaD
